Results 21 to 30 of about 20,836,880 (230)

Safe administration of non-vitamin K antagonist oral anticoagulants

open access: yesNurse Prescribing, 2017
Atrial fibrillation (AF) is the most common type of cardiac arrhythmia. More than 1 million people in the UK have AF, and it is more prevalent in older people. It increases the risk of stroke fivefold ( Stroke Association, 2016a ). In 2009, non-vitamin K antagonist anticoagulants (NOACs) were integrated into clinical practice for the treatment of ...
Elmer J Catangui
openaire   +2 more sources

Bibliometric Analysis of Non-Vitamin K Antagonist Oral Anticoagulants (NOACS) in the Prevention of Venous Thrombosis and Pulmonary Embolism. [PDF]

open access: yesDrug Des Devel Ther
Fangyi Zhou,1– 4 Zicheng Pang,1,4,5 Zhuoming Chen,6 Kai Hu,4,7 Jian Luo,1,4 Sihui Huang,8 Qiang Qu1,4 1Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People’s Republic of China; 2Teaching and Research Section
Zhou F   +6 more
europepmc   +2 more sources

Safety and efficacy of non-vitamin K antagonist oral anticoagulants for prevention of thromboembolism in adults with systemic right ventricle: Results from the NOTE international registry. [PDF]

open access: yes, 2021
BACKGROUND Patients with systemic right ventricle (sRV), including transposition of great arteries (TGA) after atrial switch procedure and congenitally corrected transposition of great arteries (ccTGA), may require anticoagulation for thromboembolism (
Fernandes, Susan M   +87 more
core   +1 more source

Early use of non-vitamin K antagonist oral anticoagulants after cardiac surgery compared with warfarin for postoperative atrial fibrillation. [PDF]

open access: yesANZ J Surg
Background The introduction of non-vitamin-K-antagonist oral anticoagulants (NOAC) has shifted the landscape of anticoagulation in the setting of atrial fibrillation (AF), as an alternative to warfarin.
Chang S   +5 more
europepmc   +2 more sources

Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome [PDF]

open access: yesRheumatology, 2016
The current treatment of thrombotic APS patients includes long-term anticoagulation with oral vitamin K antagonists (VKAs), with warfarin being the one most commonly used. However, the use of VKAs can be challenging, especially in patients with APS.
Sciascia, Savino   +5 more
openaire   +4 more sources

Non-vitamin K antagonist oral anticoagulants for COVID-19 thrombosis

open access: yesJournal of Acute Disease, 2022
Thrombotic complications appear to be a major predictor of death in COVID-19 patients, and multiple studies have shown that anticoagulants can help to improve the outcome.
Adel Khalifa Sultan Hamad
doaj   +1 more source

The Role of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation: Treatment Management Based on Patient and Drug Characteristics

open access: yes, 2022
Data from Turkey revealed that atrial fibrillation patient percentage under adequate anticoagulation in Turkey is less than that in other countries due to multiple parameters such as treatment adherence problems, failure to follow guideline ...
Erdem Gürkaş   +31 more
core   +1 more source

Supplemental Material, sj-docx-1-cpt-10.1177_10742484211049919 - Factors Influencing the Selection of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Non-Valvular Atrial Fibrillation

open access: yes, 2021
Supplemental Material, sj-docx-1-cpt-10.1177_10742484211049919 for Factors Influencing the Selection of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Non-Valvular Atrial Fibrillation by Susin Park and Nam Kyung Je in
Susin Park (11479394)   +1 more
core   +2 more sources

Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

open access: yesHellenic Journal of Cardiology, 2021
Aim: The SAMe-TT2R2 score helps identify patients with atrial fibrillation (AF) likely to have poor anticoagulation control during anticoagulation with vitamin K antagonists (VKA) and those with scores >2 might be better managed with a target-specific ...
George Ntaios   +903 more
doaj   +1 more source

Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature)

open access: yesУчёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, 2020
Review discusses the problem of non-vitamin K antagonist oral anticoagulants safety in patients with non-valvular atrial fibrillation. Bleeding risk assessment while applying anticoagulant therapy, preventive methods for major bleeding (intracranial ...
E. I. Baranova   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy